Tekora Nichols, LCSW-C in Belcamp, MD - Social Worker

Tekora Nichols, LCSW-C is a Social Worker - Clinical based in Belcamp, Maryland. Tekora Nichols is licensed to practice in Maryland (license number 17336) and her current practice location is 1307 Liatris Ln, Belcamp, Maryland. She can be reached at her office (for appointments etc.) via phone at (240) 370-9479.

NPI number for Tekora Nichols is 1609264449 and her current mailing address is 1307 Liatris Ln, Belcamp, Maryland. She does not participate in medicare program and thus does not accept medicare assignments. Her NPI Number is 1609264449.

Contact Information

	Tekora Nichols, LCSW-C
	1307 Liatris Ln, Belcamp, MD 21017-1660
	(240) 370-9479
	Not Available

Healthcare Provider's Profile

Full Name	Tekora Nichols
Gender	Female
Speciality	Social Worker - Clinical
Location	1307 Liatris Ln, Belcamp, Maryland
Accepts Medicare Assignments	Does not participate in Medicare Program. She may not accept medicare assignment.

NPI Data:

NPI Number: 1609264449
Provider Enumeration Date: 01/01/2015
Last Update Date: 01/01/2015

Medical Identifiers

Medical identifiers for Tekora Nichols such as npi, medicare ID, medicare PIN, medicaid, etc.

Identifier	Type	State	Issuer
1609264449	NPI	-	NPPES

Medical Taxonomies and Licenses

Taxonomy	Type	License (State)	Status
1041C0700X	Social Worker - Clinical	17336 (Maryland)	Primary

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Tekora Nichols is NOT enrolled with medicare and thus cannot prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing Address	Practice Location Address
Tekora Nichols, LCSW-C 1307 Liatris Ln, Belcamp, MD 21017-1660 Ph: (240) 370-9479	Tekora Nichols, LCSW-C 1307 Liatris Ln, Belcamp, MD 21017-1660 Ph: (240) 370-9479

News Archive

Effects of unhealthy lifestyle persist even after atherosclerosis treatment

Almost everyone knows that improving your eating habits will most likely improve your health. What most people may not know, however, is that the effects of poor eating habits persist long after dietary habits are improved. In a new report appearing in the November 2014 issue of the Journal of Leukocyte Biology, scientists use mice to show that even after successful treatment of atherosclerosis (including lowering of blood cholesterol and a change in dietary habits) the effects of an unhealthy lifestyle still affect the way the immune system functions.

Rosiglitazone slows progression of cachexia in cancer affected mice

Insulin resistance, the hallmark of type 2 diabetes and a condition often associated with obesity, is paradoxically also an apparent contributor to muscle wasting and severe fat loss that accompanies some cancers, according to new research.

Development of noninvasive imaging and treatment of the heart chronicled in a new article

Fifty-one years ago the average American home cost $30,000, Elvis Presley wooed listeners with Hard Headed Woman, and the hula hoop was introduced. That same year, 1958, a team comprised of a groundbreaking engineer - Dean Franklin - in concert with two exceptional physicians - Drs. Robert Rushmer and Robert Van Citters - was laying the foundation for what would eventually become a radical new approach to health care: the noninvasive imaging and treatment of the heart.

Trubion Pharmaceuticals to present promising data from Phase 1 studies of SBI-087, SBI-087

Trubion Pharmaceuticals, Inc. today announced the acceptance of two Phase 1 data presentations on SBI-087 (PF-05230895) at the 2010 annual congress of the European League Against Rheumatism (EULAR) in Rome, Italy. Presentations will include promising data from a Phase 1 study of SBI-087 for the treatment of rheumatoid arthritis (RA) and a Phase 1 study of SBI-087 for the treatment of systemic lupus erythematosus (SLE). Copies of both abstracts are available at http://www.eular.org. SBI-087 is Trubion's next-generation CD20-directed small modular immunopharmaceutical (SMIP™) product candidate and is being developed in collaboration with Pfizer.

Social Worker in Belcamp, MD

Jessica Van Brunt Hobgood, LCSW-C Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 4320 Horner Ln, Belcamp, MD 21017 Phone: 443-994-7328
Devino G Sinclair, LCSW-C Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 1370 Brass Mill Rd, Belcamp, MD 21017 Phone: 410-297-4100

Tekora Nichols, LCSW-C - Clinical Social Worker in Belcamp, MD